(Date:11/4/2009)... , MADISON, N.J., Oct. 20 /PRNewswire-FirstCa...), the world,s leading provider of diagnostic test...the third quarter ended September 30, 2009, income...or $1.02 per diluted share, from $160 million, or ...2008. In 2008, third quarter results were reduced ...
(Date:11/4/2009)... , BEDFORD, Mass., Oct. 20 /PRNewswire-FirstC...pplier of broadband technology and biometrics soft...rd quarter ended September 30, 2009. ,, Mich...Officer, said, "Earlier today, we announced an agr... lines to Lantiq, a new fabless semiconductor comp...
(Date:11/4/2009)... , CARLSBAD, Calif., Oct. 23 ...ature biosample management for genomic discovery, ...David Wellis, Ph.D., GenVault,s President and CEO,...nce taking place on October 26th and 27th in La Jo... will provide an overview of the company together ...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2China Sky One Medical Inc Obtains Renewal of GMP Certificate 51605 1China Sky One Medical Inc Obtains Renewal of GMP Certificate 51605 2China Sky One Medical Inc Obtains Renewal of GMP Certificate 51605 3Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 1Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 2Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 3Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 1Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 2Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 3Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 4(Date:11/6/2009)...ov. 6 Helix BioPharma Co...nnounced that John Docherty, president and chief o...Ford,s 6th annual Investor Summit on November 10, ...ity. Mr. Docherty will provide an overview of the...DOS47 and Topical Interferon Alpha-2b. The slide ...
(Date:11/6/2009)...RNewswire-FirstCall/ - Oncolytics Biotech Inc. (TS...) today announced updated results from a Phase II ...sarcomas metastatic to the lung in a poster presen...gy Society Meeting held in Miami Beach, Florida, f...entitled "A Phase II Study of Intravenous REOLYSIN...
(Date:11/5/2009)... Nov. 5 The endangered black-foote... U.S. This rare carnivore feeds on prairie dogs. ...and often entire population die-offs in towns occu... implemented a ferret breeding program and has bee...rmerly native habitat. Unfortunately, plague can ...
(Date:11/5/2009)...5 Transgenomic, Inc. (OT...results for the quarter ended September 30, 2009. ...he tables that follow. ,, Third Quarter 2009 ...or $0.01 per share for the third quarter of 2009 a...share for the third quarter of 2008. ,, Net sa...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7...tory affairs group based in Ann ... United BioSource Corporation,(UBC) today announce...d by,distinguished experts Mark Ammann, Pharm.D. a...an, the group will provide a full range of service...luding creating and,implementing development plans...
...IAN(TM) CRT-D and upgraded LATITUD...b. 25 Boston Scientific,Corporation (NYSE: BSX )...,(FDA) approval for three products in its Cardiac ...ONFIENT(TM) implantable cardioverter defibrillator...of sudden cardiac death, -- The LIVIAN(TM) cardi...
...Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced t...cal trial with AZ-004 (Staccato(R) loxapine). AZ-0...ped for the treatment of,acute agitation in patien...believes the novel, non-invasive nature and rapid ...aled loxapine administration via the Staccato,syst...
Other Biology Technology:United BioSource Expands Regulatory Affairs Capabilities 2Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 2Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 3Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
... Customer Peptide Synthesis , 20 Amino Acid leng...g will return to customer for future usage conjuga... Maintenance 102 days/each , Pre-immune bleed ...each , Test bleed (app. 5 ml) x1 /each , Pr...
6% PAGE/Urea Solution (19:1 Acrylamide/Bis + 6 M Urea) from Ambion
...unogen: Synthetic peptide derived from the interna...: Specific for the junctophilin-1 protein. Reacti...eletal muscle homogenates frozen mouse brain and s...otting Immunohistochemistry(froz) Immunofluorescen...
Biology Products: